Mamatha Kambalapalli

MD | Pediatric Endocrinology | Female

Mamatha Kambalapalli, MD is a Akron, Ohio based Pediatric doctor with medical specialization in Pediatric Endocrinology. Current practice location of Mamatha Kambalapalli is 1 Perkins Sq, Akron, Ohio - 44308-1063. She can be contacted on phone at 330-543-3276 and fax number 330-543-8489. Mamatha Kambalapalli is a sole proprietor of her business.
NPI number (Unique professional ID) for Mamatha Kambalapalli is 1134379670 which was assigned by NPPES on 20 Sep, 2008 and it was last updated on 10 Mar, 2015. Mamatha Kambalapalli license number is 35.122943 for Pediatrics Pediatric Endocrinology (2080P0205X) in Ohio.
Mamatha Kambalapalli provides expert care to infants, children and adolescents who have diseases that result from an abnormality in the endocrine glands (glands which secrete hormones). These diseases include diabetes mellitus, growth failure, unusual size for age, early or late pubertal development, birth defects, the genital region and disorders of the thyroid, the adrenal and pituitary glands.
Complete Profile:
Mamatha Kambalapalli basic information including her official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics Pediatric Endocrinology
Provider Name :Mamatha Kambalapalli
Credential :MD
Gender :Female
Business Address:
Mamatha Kambalapalli address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :1 Perkins Sq
Akron, OH, 44308-1063
United States
Phone Number :330-543-3276
Fax Number :330-543-8489
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1134379670
NPI Entity Type : Individual
First Enrolment Date : 20 Sep, 2008
Last Updated On : 10 Mar, 2015
Medicare Participation:
Mamatha Kambalapalli participates in medicare and accepts medicare insurance either directly or through association with group practice or medical facility.
Medicare PECOS ID :7911147178
Medicare Enrollment ID :I20140813002317
Primary Specialty :Endocrinology
Medical School :Other
Graduation Year :1999
Accepts Medicare?Yes. Mamatha Kambalapalli accepts medicare insurance.
Group Practice Association:
Mamatha Kambalapalli is associated with following Group Practice Organizations. Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Mamatha Kambalapalli is associated with along with the number of members in that group. She may also accept medicare indirectly via these group practices.
Organisation Name :Group Practice IDNo. of MembersPractice AddressGroup Accepts Medicare
Children's Hospital Medical Center Of Akron06481830121241 Perkins Sq
Akron, OH - 443081063
Ph: 3305431000
Yes
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mamatha Kambalapalli are as mentioned. Primary taxonomy code for Mamatha Kambalapalli, MD is 2080P0205X (Pediatrics Pediatric Endocrinology).
Taxonomy Code SpecialityPrimaryLicense No.State
208000000XPediatricsNo35.122943OH
2080P0205XPediatrics Pediatric EndocrinologyYes35.122943OH
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :1 Perkins Sq
Akron, OH, 44308-1063
United States
Phone Number :330-543-3276
Fax Number :330-543-8489
Business Location:
Patients can refer following map for directions to Mamatha Kambalapalli practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.